In this review
Availability changes the recommendation
The most important CRE-C20 specification is now its sales status. Sony says CRE-C10, CRE-C20 and CRE-E10 sales were discontinued around May 26, 2026. The CRE-C20 storefront marks the item no longer available, while retaining a $999.99 price. [1] [2] I would not use that number as a current Sony checkout offer or compare it uncritically with a retailer’s clearance listing.
For a new buyer, I favor a currently sold alternative unless the remaining-stock offer has a compelling, documented advantage. A low price can be useful, but hearing aids are not a purchase I would make on price alone. Fit, adjustments, repair arrangements and the ability to return an unsuitable pair are part of what you are buying. A discount becomes less attractive if those pieces are uncertain. Set aside the familiar brand name for a moment and compare the complete offer. A currently supported service with a clear adjustment process may justify a higher price, while a remaining-stock pair with uncertain returns can be poor value even if the box is sealed. The useful comparison includes what happens after the initial fitting does not immediately feel right.
For a currently marketed service comparison, read our Jabra Enhance Select review.
Support continues, but a listing is not a warranty
Sony says post-purchase support and service continue in accordance with the limited warranty accompanying the product and applicable law. [2] That statement should reassure an existing owner more than an anonymous remaining-stock listing. It does not turn every seller’s offer into an authorized purchase or establish an unlimited service commitment.
Before paying for old stock, get the exact model, product condition, seller identity, warranty eligibility and return deadline in writing. Open-box and previously worn hearing aids deserve particular attention to hygiene, missing accessories and return conditions. I would not borrow the benefits shown on an unavailable direct-store page and assume a different merchant must provide them. The seller’s actual terms govern the purchase you are making, and the receipt should be worth keeping.
A discreet hearing aid is not a streaming earbud
CRE-C20 is a rechargeable, self-fitting in-canal hearing aid. Sony describes setup and adjustments through its Hearing Control app, and the setup instructions require a Sony account. [1] [3] That can suit a person comfortable using a phone to make adjustments. It is less attractive if managing accounts and app compatibility is already a recurring source of frustration.
Phone setup also does not mean phone-audio streaming. Sony specifically says CRE-C20 cannot stream music or videos from a smartphone. [4] For someone who wants calls, podcasts and hearing support in the same device, that limitation can settle the shortlist before any small price difference matters. For someone who mainly wants a discreet aid for conversation, it may be an acceptable compromise. Decide which use is essential before treating the small format as an all-purpose advantage.
Choose the service level as carefully as the device
OTC hearing aids are for adults with perceived mild-to-moderate hearing loss. FDA guidance distinguishes that pathway from circumstances needing medical attention, including sudden hearing changes or pain. [5] An online bargain does not resolve whether OTC self-fitting is appropriate for the difficulty you are experiencing. Start there if the situation is new, asymmetric or otherwise concerning.
For a current comparison, look at the support model in Jabra Enhance Select rather than assuming every hearing-aid purchase includes the same adjustment help. Our ACHIEVE explanation also separates hearing intervention from promises about preventing cognitive decline. I would buy hearing support to improve a concrete listening problem, not to obtain an assumed dementia-prevention benefit. Existing CRE-C20 owners should keep using Sony’s support resources; new buyers should require a clear reason to choose discontinued stock over an available service with understandable continuing care.
For the evidence behind a different kind of hearing claim, see what ACHIEVE found about hearing and cognition.
The difference between a measured cognitive score and demonstrated dementia prevention also appears in the modest cognitive-test findings in COSMOS.
Understanding the cost
Sony’s unavailable product page retains a $999.99 reference price; this is not a current purchasable offer. Any remaining-stock price and return terms are seller-specific.
Build your cost estimateSources
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.